window-to-japan.eu

Window to Japan

DNAVEC starts production of iPS cells based on a Sendai virus vector

By schmid_wordpressPosted on Posted in News

The production is directed towards clinical application and based on the use of a Sendai virus “GMP-CytoTune-iPS” under GMP standards.

DNAVEC website news, Nov. 13, 2014

DNAVEC starts production of iPS cells based on a Sendai virus vector
Scroll to top